Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials.
Piccolo R, Bonaa KH, Efthimiou O, Varenne O, Baldo A, Urban P, Kaiser C, Remkes W, Räber L, de Belder A, van 't Hof AWJ, Stankovic G, Lemos PA, Wilsgaard T, Reifart J, Rodriguez AE, Ribeiro EE, Serruys PWJC, Abizaid A, Sabaté M, Byrne RA, de la Torre Hernandez JM, Wijns W, Jüni P, Windecker S, Valgimigli M; Coronary Stent Trialists' Collaboration. Piccolo R, et al. Among authors: raber l. Lancet. 2019 Jun 22;393(10190):2503-2510. doi: 10.1016/S0140-6736(19)30474-X. Epub 2019 May 2. Lancet. 2019. PMID: 31056295
Human vs. machine vs. core lab for the assessment of coronary atherosclerosis with lumen and vessel contour segmentation with intravascular ultrasound.
Bass RD, Garcia-Garcia HM, Sanz-Sánchez J, Ziemer PGP, Bulant CA, Kuku KK, Kahsay YA, Beyene S, Melaku G, Otsuka T, Choi J, Fernández-Peregrina E, Erdogan E, Gonzalo N, Bourantas CV, Blanco PJ, Räber L. Bass RD, et al. Among authors: raber l. Int J Cardiovasc Imaging. 2022 Jul;38(7):1431-1439. doi: 10.1007/s10554-022-02563-6. Epub 2022 Apr 19. Int J Cardiovasc Imaging. 2022. PMID: 38819542
Pericardial Effusion After Left Atrial Appendage Closure: Timing, Predictors, and Clinical Impact.
Galea R, Bini T, Krsnik JP, Touray M, Temperli FG, Kassar M, Papadis A, Gloeckler S, Brugger N, Madhkour R, Seiffge DJ, Roten L, Siontis GCM, Heg D, Windecker S, Räber L. Galea R, et al. Among authors: raber l. JACC Cardiovasc Interv. 2024 Mar 6:S1936-8798(24)00403-5. doi: 10.1016/j.jcin.2024.01.310. Online ahead of print. JACC Cardiovasc Interv. 2024. PMID: 38795087
Effect of Alirocumab on Carotid Inflammation by [18F]FDG PET in Patients With Acute Myocardial Infarction.
Bang LE, Jensen JK, Räber L, Koskinas KC, Bär S, Losdat S, Matter CM, Lonborg J, Radu Juul Jensen MD, Kjaer A, Engstrøm T, Ripa RS. Bang LE, et al. Among authors: raber l. JACC Cardiovasc Imaging. 2024 Apr 10:S1936-878X(24)00131-1. doi: 10.1016/j.jcmg.2024.04.001. Online ahead of print. JACC Cardiovasc Imaging. 2024. PMID: 38678449 No abstract available.
Safety and effectiveness of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the SPUM-ACS study.
Bruno F, Wenzl FA, De Filippo O, Kraler S, Giacobbe F, Roffi M, Muller O, Räber L, Templin C, Maria De Ferrari G, D'Ascenzo F, Lüscher TF. Bruno F, et al. Among authors: raber l. Eur Heart J Cardiovasc Pharmacother. 2024 Apr 11:pvae024. doi: 10.1093/ehjcvp/pvae024. Online ahead of print. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38604747
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
Rexhaj E, Bär S, Soria R, Ueki Y, Häner JD, Otsuka T, Kavaliauskaite R, Siontis GC, Stortecky S, Shibutani H, Spirk D, Engstrøm T, Lang I, Morf L, Ambühl M, Windecker S, Losdat S, Koskinas KC, Räber L; PACMAN-AMI Investigators. Rexhaj E, et al. Among authors: raber l. Atherosclerosis. 2024 May;392:117504. doi: 10.1016/j.atherosclerosis.2024.117504. Epub 2024 Mar 6. Atherosclerosis. 2024. PMID: 38513436 Free article. Clinical Trial.
Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes.
Eppinger S, Piayda K, Galea R, Sandri M, Maarse M, Güner A, Karabay CY, Pershad A, Ding WY, Aminian A, Akin I, Davtyan KV, Chugunov IA, Marijon E, Rosseel L, Schmidt TR, Amabile N, Korsholm K, Lund J, Guerios E, Amat-Santos IJ, Boccuzzi G, Ellis CR, Sabbag A, Ebelt H, Clapp B, Assa HV, Levi A, Ledwoch J, Lehmann S, Lee OH, Mark G, Schell W, Della Rocca DG, Natale A, de Backer O, Kefer J, Esteban PP, Abelson M, Ram P, Moceri P, Galache Osuna JG, Alvarez XM, Cruz-Gonzalez I, de Potter T, Ghassan M, Osadchiy A, Chen W, Goyal SK, Giannini F, Rivero-Ayerza M, Afzal S, Jung C, Skurk C, Langel M, Spence M, Merkulov E, Lempereur M, Shin SY, Mesnier J, McKinney HL, Schuler BT, Armero S, Gheorghe L, Ancona MBM, Santos L, Mansourati J, Nombela-Franco L, Nappi F, Kühne M, Gaspardone A, van der Pals J, Montorfano M, Fernández-Armenta J, Harvey JE, Rodés-Cabau J, Klein N, Sabir SA, Kim JS, Cook S, Kornowski R, Saraste A, Nielsen-Kudsk JE, Gupta D, Boersma L, Räber L, Sievert K, Sievert H, Bertog S. Eppinger S, et al. Among authors: raber l. Cardiovasc Revasc Med. 2024 Feb 28:S1553-8389(24)00067-8. doi: 10.1016/j.carrev.2024.02.014. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38448258
406 results